Back to today’s briefing

Story perspectives

Nucleus Secures $14M for Genomic Testing Expansion

2/4/2025

38 6

Summary

Story summary

Nucleus, a New York-based genomic testing startup, has successfully secured $14 million in Series A funding, boosting its total investment to $32 million. With a mission to make whole-genome sequencing accessible, the company screens for over 800 medical conditions and has tripled its monthly users, eyeing expansion in genetic risk assessments and global markets.

1 of 1

Story summary

Nucleus, a New York-based genomic testing startup, has successfully secured $14 million in Series A funding, boosting its total investment to $32 million. With a mission to make whole-genome sequencing accessible, the company screens for over 800 medical conditions and has tripled its monthly users, eyeing expansion in genetic risk assessments and global markets.